Literature DB >> 22145653

Systemic lupus erythematosus: a genetic review for advanced practice nurses.

Marcia Robinson1, Sarah Sheets Cook, Leanne M Currie.   

Abstract

PURPOSE: To review the symptom presentation, genetic aspects, and available treatment options for individuals diagnosed with systemic lupus erythematosus (SLE). Primary care providers should be vigilant in identifying symptoms, which may be related to SLE, perform adequate assessment, and diagnostic testing in order to arrive at an early diagnosis. DATA SOURCES: Extensive literature review of textbook, clinical, medical, and nursing journals.
CONCLUSIONS: Lupus is a multigenic autoimmune disease, which requires the clinician to be hypervigilant by collecting a thorough family history and performing a complete physical assessment of the patient. There is an array of treatment modalities, both experimental and proven therapies, which improve signs and symptoms associated with SLE. Numerous medications are available for symptom management: anti-inflammatory agents for patients with musculoskeletal presentation, and steroids or antimalarials for those with more extensive organ involvement. IMPLICATIONS FOR PRACTICE: In SLE, the overall aim of management is to determine the extent of disease and prevent extensive organ involvement. Therefore, when diagnosed in a timely manner, most patients will survive and are able to manage their disease. ©2011 The Author(s) Journal compilation ©2011 American Academy of Nurse Practitioners.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22145653     DOI: 10.1111/j.1745-7599.2011.00675.x

Source DB:  PubMed          Journal:  J Am Acad Nurse Pract        ISSN: 1041-2972


  3 in total

1.  LIG4 and RAD52 DNA repair genes polymorphisms and systemic lupus erythematosus.

Authors:  Jaqueline De Azevêdo Silva; João Alexandre Trés Pancotto; Eduardo Antônio Donadi; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

Review 2.  Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance.

Authors:  Laura Holloway; Louise Humphrey; Louise Heron; Claire Pilling; Helen Kitchen; Lise Højbjerre; Martin Strandberg-Larsen; Brian Bekker Hansen
Journal:  Health Qual Life Outcomes       Date:  2014-07-22       Impact factor: 3.186

3.  Effect of targeted nursing applied to SLE patients.

Authors:  Xiangying Zhang; Yali Tian; Junbao Li; Xingli Zhao
Journal:  Exp Ther Med       Date:  2016-03-18       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.